Predictions
Alphabet Inc. A
Start price
Target price
Perf. (%)
€67.04
28.10.20
28.10.20
€0.090
04.11.21
04.11.21
91.60%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€267.50
27.10.20
27.10.20
€300.00
31.10.20
31.10.20
8.41%
31.10.20
31.10.20
Could be worthwhile Investment >10% per year
Mercedes-Benz Group AG
Start price
Target price
Perf. (%)
€46.51
27.10.20
27.10.20
€23.00
04.11.21
04.11.21
10.01%
09.11.20
09.11.20
Risky Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Advanced Micro Devices Inc.
Start price
Target price
Perf. (%)
€67.98
27.10.20
27.10.20
€72.00
04.11.21
04.11.21
4.30%
06.11.20
06.11.20
Could be worthwhile Investment >10% per year
Top 10 in its market
Small cyclical dependencies
Revenue growth >5% per year expected
Bitcoin Group SE
Start price
Target price
Perf. (%)
€27.70
27.10.20
27.10.20
€50.00
04.11.21
04.11.21
88.09%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
SPI Energy Co Ltd ADR
Start price
Target price
Perf. (%)
€9.45
27.10.20
27.10.20
€8.92
31.10.20
31.10.20
-25.93%
31.10.20
31.10.20
Risky Investment
Eutelsat Communications
Start price
Target price
Perf. (%)
€8.76
27.10.20
27.10.20
€10.00
04.11.21
04.11.21
42.97%
13.10.21
13.10.21
Could be worthwhile Investment >10% per year
Inovio Pharma
Start price
Target price
Perf. (%)
€8.90
27.10.20
27.10.20
-
04.11.21
04.11.21
-24.99%
15.07.21
15.07.21
Risky Investment
WAVE Life Sciences Ltd
Start price
Target price
Perf. (%)
€6.50
27.10.20
27.10.20
-
29.10.20
29.10.20
-0.77%
29.10.20
29.10.20
Could be very worthwhile Investment >20% year
Horizon Pharma plc
Start price
Target price
Perf. (%)
€65.45
26.10.20
26.10.20
-
28.10.20
28.10.20
0.70%
28.10.20
28.10.20
Could be very worthwhile Investment >20% year
WAVE Life Sciences Ltd
Start price
Target price
Perf. (%)
€6.60
26.10.20
26.10.20
-
27.10.20
27.10.20
-1.52%
27.10.20
27.10.20
Could be very worthwhile Investment >20% year
Inovio Pharma
Start price
Target price
Perf. (%)
€8.90
26.10.20
26.10.20
-
27.10.20
27.10.20
0.00%
27.10.20
27.10.20
Risky Investment
Muscle Maker Inc.
Start price
Target price
Perf. (%)
€1.71
26.10.20
26.10.20
-
04.11.21
04.11.21
-30.99%
05.11.21
05.11.21
Probably not worthwhile Investment
Danaher Corp.
Start price
Target price
Perf. (%)
€197.46
26.10.20
26.10.20
-
04.11.21
04.11.21
-0.33%
17.01.21
17.01.21
EBIT growth >5% per year expected
Revenue growth >5% per year expected
Increased challenges to pay loans and raise capital
Inovio Pharma
Start price
Target price
Perf. (%)
€8.95
26.10.20
26.10.20
-
26.10.20
26.10.20
-0.56%
26.10.20
26.10.20
Risky Investment
Inovio Pharma
Start price
Target price
Perf. (%)
€9.25
26.10.20
26.10.20
-
26.10.20
26.10.20
-3.24%
26.10.20
26.10.20
Risky Investment
Citigroup Inc.
Start price
Target price
Perf. (%)
€36.88
25.10.20
25.10.20
-
04.11.21
04.11.21
36.61%
02.01.21
02.01.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
High dividend yield expected
Deutsche Börse AG
Start price
Target price
Perf. (%)
€136.05
25.10.20
25.10.20
-
04.11.21
04.11.21
2.65%
02.01.21
02.01.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Borr Drilling Ltd
Start price
Target price
Perf. (%)
€0.71
24.10.20
24.10.20
€1.60
04.11.21
04.11.21
158.58%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
FirstEnergy Corp.
Start price
Target price
Perf. (%)
€28.20
24.10.20
24.10.20
€32.00
04.11.21
04.11.21
25.90%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Liberty Media Corp
Start price
Target price
Perf. (%)
€18.60
24.10.20
24.10.20
€23.00
04.11.21
04.11.21
41.94%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€51.03
24.10.20
24.10.20
€58.00
04.11.21
04.11.21
-0.20%
11.11.20
11.11.20
Medium risks for its business
Risky Investment
Deutsche Bank AG
Start price
Target price
Perf. (%)
€7.98
23.10.20
23.10.20
€9.00
04.11.21
04.11.21
7.12%
05.11.20
05.11.20
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group